Massachusetts Financial Services Co. MA boosted its stake in shares of ZimVie Inc. (NASDAQ:ZIMV – Free Report) by 61.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 161,344 shares of the company’s stock after acquiring an additional 61,335 shares during the period. Massachusetts Financial Services Co. MA owned about 0.58% of ZimVie worth $2,251,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. SG Americas Securities LLC raised its position in shares of ZimVie by 15.7% during the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after purchasing an additional 1,508 shares during the last quarter. EMC Capital Management raised its holdings in shares of ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company’s stock valued at $193,000 after acquiring an additional 4,414 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of ZimVie by 9.8% in the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock valued at $266,000 after acquiring an additional 1,702 shares in the last quarter. Bailard Inc. lifted its position in shares of ZimVie by 35.0% in the fourth quarter. Bailard Inc. now owns 21,194 shares of the company’s stock valued at $296,000 after acquiring an additional 5,494 shares in the last quarter. Finally, Fox Run Management L.L.C. acquired a new stake in shares of ZimVie in the fourth quarter worth approximately $463,000. 95.63% of the stock is owned by hedge funds and other institutional investors.
ZimVie Stock Down 2.2 %
Shares of NASDAQ ZIMV opened at $9.13 on Wednesday. The stock has a market cap of $254.24 million, a PE ratio of -0.70 and a beta of 2.14. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 12-month low of $8.94 and a 12-month high of $22.40. The company has a 50-day moving average of $12.33 and a 200 day moving average of $13.66.
Analyst Ratings Changes
Separately, Needham & Company LLC restated a “hold” rating on shares of ZimVie in a report on Thursday, March 13th.
Read Our Latest Analysis on ZimVie
ZimVie Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Further Reading
- Five stocks we like better than ZimVie
- What is the Dow Jones Industrial Average (DJIA)?
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- What is the Shanghai Stock Exchange Composite Index?
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- 5 Top Rated Dividend Stocks to Consider
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.